15.1
僧帽弁逸脱症 I: はじめに
はじめに
僧帽弁は、心臓の四つの弁の一つで、血液の流れを調節します。これらの弁はフラップを持ち、心臓と体内で血液を適切に導くために開閉します。心拍ごとに、フラップは血液が通過できるように開き、逆流を防ぐために閉じます。特に、僧帽弁は、心臓の上部の左心房から下部の左室に血液が流れることを許可し、その後…
僧帽弁脱出症(MVP)は、僧帽弁尖、乳頭筋、または腱脊索の異常により、収縮期に弁尖が脱出または左心房に戻ることを可能にする心臓病です。
MVP はさまざまな要因から発生する可能性があります。
粘液腫性変性による僧帽弁の構造変化は一般的です。
マルファン症候群のような結合組織障害に関連する遺伝的要因も寄与しています。
その他の原因には、先天性奇形、加齢に伴う変性変化、脊柱側弯症や筋ジストロフィーなどの骨格疾患が含まれます。
MVPの病因は、過剰なコラーゲンとプロテオグリカンによる弁フラップの肥厚から始まり、弁が垂れ下がって脱出しやすくなります。
心臓の収縮期または収縮期には、拡大した弁フラップが左心房に後方に膨らみ、異常な弁閉鎖につながる可能性があります。
弁フラップを心臓の乳頭筋につなげている腱索が弱くなり、弁の機能がさらに損なわれる可能性があります。
その結果、収縮期に血液が左心房に逆流する僧帽弁逆流を引き起こし、心房細動、肺高血圧症、心不全などの合併症を引き起こします。
View the full transcript and gain access to JoVE Core videos
Q1: What happens to the mitral valve during mitral valve prolapse?
During mitral valve prolapse, the mitral valve leaflets abnormally bulge backward into the left atrium during systole, the heart's contraction phase. This occurs when the valve leaflets become thickened and enlarged due to myxomatous degeneration, making them floppy and prone to prolapse. The weakened chordae tendineae, which anchor the leaflets to papillary muscles, further impair proper valve closure.
Q2: What structural changes cause mitral valve prolapse?
Mitral valve prolapse results from thickening of valve leaflets due to excess collagen and proteoglycans, a process called myxomatous degeneration. This abnormal tissue accumulation makes the leaflets spongy and enlarged. Additionally, alterations in the chordae tendineae weaken the cords anchoring the valve to the heart muscle, compromising the valve's ability to close properly during systole.
Q3: How does genetic predisposition contribute to mitral valve prolapse?
Genetic factors play a significant role in mitral valve prolapse development. The condition is often inherited and commonly associated with connective tissue disorders like Marfan syndrome, Ehlers-Danlos syndrome, and osteogenesis imperfecta. These inherited disorders affect the body's connective tissues, leading to structural abnormalities in the mitral valve that predispose individuals to prolapse.
Q4: What complications can result from mitral valve prolapse?
Mitral valve prolapse can lead to mitral regurgitation, where blood rushes backward into the left atrium during systole. This causes volume overload in the left atrium and may result in left atrial and left ventricular enlargement. Significant mitral regurgitation can trigger serious complications including atrial fibrillation, pulmonary hypertension, and heart failure.
Q5: What non-genetic factors contribute to mitral valve prolapse development?
Beyond genetic factors, mitral valve prolapse can develop from congenital malformations, age-related degenerative changes in valve leaflets, and skeletal conditions like scoliosis, chest wall deformities, and muscular dystrophies. Developmental abnormalities occurring during the fetal stage may also predispose individuals to MVP. Additionally, evidence suggests higher prevalence in women, though the reasons remain unclear.
Q6: How does the mitral valve normally function in the heart?
The mitral valve regulates blood flow from the heart's upper left chamber (left atrium) to the lower left chamber (left ventricle). During each heartbeat, the valve opens to allow blood passage and closes securely as the ventricle contracts to pump blood to the body. This prevents backflow and ensures unidirectional blood circulation through the heart.
Q7: What role do papillary muscles and chordae tendineae play in mitral valve function?
The chordae tendineae are cords that anchor the mitral valve leaflets to the papillary muscles, specialized heart muscle structures. Together, they stabilize the valve leaflets and ensure proper closure during systole. When these structures weaken or become altered, the valve leaflets cannot close smoothly, increasing the likelihood of prolapse and valve dysfunction.